DK2571488T3 - Farmaceutisk komposition af ibuprofen til injektion - Google Patents

Farmaceutisk komposition af ibuprofen til injektion

Info

Publication number: DK2571488T3
Authority: DK; Denmark
Prior art keywords: ibuprofen; injection; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2010-05-18

Application number

DK11720479T

Other languages

English (en)

Other versions

DK2571488T4 (da

Inventor

Zar Andéchaga Ignacio Ort

Zar Gutiérrez Mario Ort

Original Assignee

Spain Pharma S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-05-18

Filing date

2011-05-18

Publication date

2014-07-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43589415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2571488(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-05-18 Application filed by Spain Pharma S A filed Critical Spain Pharma S A

2014-07-14 Publication of DK2571488T3 publication Critical patent/DK2571488T3/da

2017-08-28 Application granted granted Critical

2017-08-28 Publication of DK2571488T4 publication Critical patent/DK2571488T4/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK11720479.2T 2010-05-18 2011-05-18 Farmaceutisk komposition af ibuprofen til injektion DK2571488T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/ES2010/070330 WO2011144766A1 (es)	2010-05-18	2010-05-18	Composición farmacéutica de ibuprofeno para inyección
PCT/EP2011/058087 WO2011144677A1 (en)	2010-05-18	2011-05-18	Pharmaceutical composition of ibuprofen for injection

Publications (2)

Publication Number	Publication Date
DK2571488T3 true DK2571488T3 (da)	2014-07-14
DK2571488T4 DK2571488T4 (da)	2017-08-28

Family

ID=43589415

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK11720479.2T DK2571488T4 (da)	2010-05-18	2011-05-18	Farmaceutisk komposition af ibuprofen til injektion

Country Status (35)

Country	Link
US (1)	US9114165B2 (da)
EP (1)	EP2571488B2 (da)
JP (1)	JP6018048B2 (da)
KR (1)	KR101770808B1 (da)
CN (1)	CN102892410B (da)
AU (1)	AU2011254583B2 (da)
BR (1)	BR112012029171B1 (da)
CA (1)	CA2798575C (da)
CL (1)	CL2012003119A1 (da)
CO (1)	CO6650419A2 (da)
CR (1)	CR20120559A (da)
CY (1)	CY1115394T1 (da)
DK (1)	DK2571488T4 (da)
EC (1)	ECSP12012274A (da)
ES (1)	ES2478491T5 (da)
HR (1)	HRP20140622T4 (da)
IL (1)	IL222497A0 (da)
MA (1)	MA34176B1 (da)
ME (1)	ME01834B (da)
MX (1)	MX2012013402A (da)
MY (1)	MY160302A (da)
NZ (1)	NZ602957A (da)
PE (1)	PE20130374A1 (da)
PH (1)	PH12012502274A1 (da)
PL (1)	PL2571488T5 (da)
PT (1)	PT2571488E (da)
RS (1)	RS53408B2 (da)
RU (1)	RU2012154628A (da)
SG (1)	SG185061A1 (da)
SI (1)	SI2571488T2 (da)
SM (1)	SMT201400103B (da)
TN (1)	TN2012000487A1 (da)
UA (1)	UA103290C2 (da)
WO (2)	WO2011144766A1 (da)
ZA (1)	ZA201207948B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9072710B2 (en) *	2012-03-16	2015-07-07	Cumberland Pharmaceuticals Inc.	Injectable ibuprofen formulation
CN104323988A (zh) *	2014-11-27	2015-02-04	北京蓝丹医药科技有限公司	一种用于注射的右旋布洛芬药物组合物
CN105055389B (zh) *	2015-08-03	2018-08-10	北京蓝丹医药科技有限公司	一种用于早产儿先天性心脏病的布洛芬药物组合物
CN105997901A (zh) *	2016-07-27	2016-10-12	济南东方开元医药新技术有限公司	小儿注射用布洛芬氨丁三醇冻干粉针组合物及制备方法
ES3036668T3 (en) *	2018-12-14	2025-09-23	Fresenius Kabi Austria Gmbh	Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer
CN112526013B (zh) *	2020-11-20	2022-09-06	人福普克药业（武汉）有限公司	超高液相色谱法检测布洛芬药物中有关物质浓度方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19912436A1 (de) *	1999-03-19	2000-09-21	Merckle Gmbh	Ibuprofen-Lösung
US20040132823A1 (en)	2001-11-02	2004-07-08	Leo Pavliv	Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
DE60114249T2 (de)	2001-11-02	2006-05-18	Cumberland Pharmaceuticals Inc., Nashville	Pharmazeutische zusammensetzung mit 2-(4-isobutylphenyl) propionsäure
ITMI20040235A1 (it)	2004-02-13	2004-05-13	Therapicon Srl	Preparazione farmaceutica per il cavo orale

2010
- 2010-05-18 WO PCT/ES2010/070330 patent/WO2011144766A1/es not_active Ceased
2011
- 2011-05-18 US US13/641,921 patent/US9114165B2/en active Active
- 2011-05-18 CA CA2798575A patent/CA2798575C/en active Active
- 2011-05-18 AU AU2011254583A patent/AU2011254583B2/en active Active
- 2011-05-18 ME MEP-2014-74A patent/ME01834B/me unknown
- 2011-05-18 PT PT11720479T patent/PT2571488E/pt unknown
- 2011-05-18 DK DK11720479.2T patent/DK2571488T4/da active
- 2011-05-18 WO PCT/EP2011/058087 patent/WO2011144677A1/en not_active Ceased
- 2011-05-18 NZ NZ60295711A patent/NZ602957A/en unknown
- 2011-05-18 SG SG2012079570A patent/SG185061A1/en unknown
- 2011-05-18 MA MA35330A patent/MA34176B1/fr unknown
- 2011-05-18 MX MX2012013402A patent/MX2012013402A/es active IP Right Grant
- 2011-05-18 MY MYPI2012700890A patent/MY160302A/en unknown
- 2011-05-18 RS RS20140366A patent/RS53408B2/sr unknown
- 2011-05-18 PL PL11720479T patent/PL2571488T5/pl unknown
- 2011-05-18 ES ES11720479.2T patent/ES2478491T5/es active Active
- 2011-05-18 UA UAA201214485A patent/UA103290C2/ru unknown
- 2011-05-18 HR HRP20140622TT patent/HRP20140622T4/hr unknown
- 2011-05-18 BR BR112012029171-8A patent/BR112012029171B1/pt active IP Right Grant
- 2011-05-18 SI SI201130206T patent/SI2571488T2/sl unknown
- 2011-05-18 EP EP11720479.2A patent/EP2571488B2/en active Active
- 2011-05-18 PH PH1/2012/502274A patent/PH12012502274A1/en unknown
- 2011-05-18 JP JP2013510623A patent/JP6018048B2/ja active Active
- 2011-05-18 KR KR1020127032850A patent/KR101770808B1/ko active Active
- 2011-05-18 RU RU2012154628/15A patent/RU2012154628A/ru unknown
- 2011-05-18 CN CN201180024380.7A patent/CN102892410B/zh not_active Ceased
- 2011-05-18 PE PE2012002182A patent/PE20130374A1/es not_active Application Discontinuation
2012
- 2012-10-09 TN TNP2012000487A patent/TN2012000487A1/en unknown
- 2012-10-17 EC ECSP12012274 patent/ECSP12012274A/es unknown
- 2012-10-17 IL IL222497A patent/IL222497A0/en unknown
- 2012-10-22 ZA ZA2012/07948A patent/ZA201207948B/en unknown
- 2012-11-01 CR CR20120559A patent/CR20120559A/es unknown
- 2012-11-07 CL CL2012003119A patent/CL2012003119A1/es unknown
- 2012-12-17 CO CO12228358A patent/CO6650419A2/es unknown
2014
- 2014-07-29 SM SM201400103T patent/SMT201400103B/xx unknown
- 2014-07-30 CY CY20141100574T patent/CY1115394T1/el unknown

Also Published As

Publication number	Publication date
US20130231390A1 (en)	2013-09-05
SMT201400103B (it)	2014-09-08
HK1177424A1 (en)	2013-08-23
ZA201207948B (en)	2013-06-26
PH12012502274A1 (en)	2013-02-04
JP2013529205A (ja)	2013-07-18
IL222497A0 (en)	2012-12-31
WO2011144677A1 (en)	2011-11-24
ME01834B (me)	2014-12-20
HRP20140622T4 (hr)	2017-10-06
BR112012029171A2 (pt)	2017-07-18
PT2571488E (pt)	2014-07-25
NZ602957A (en)	2014-09-26
ES2478491T5 (es)	2017-11-21
KR101770808B1 (ko)	2017-08-23
SI2571488T2 (sl)	2017-09-29
WO2011144766A1 (es)	2011-11-24
CN102892410A (zh)	2013-01-23
HRP20140622T1 (en)	2014-09-26
EP2571488B1 (en)	2014-06-18
PE20130374A1 (es)	2013-03-30
ECSP12012274A (es)	2013-02-28
EP2571488B2 (en)	2017-07-26
MX2012013402A (es)	2013-01-17
KR20130109007A (ko)	2013-10-07
CL2012003119A1 (es)	2013-06-07
CY1115394T1 (el)	2017-01-04
SG185061A1 (en)	2012-12-28
RS53408B (sr)	2014-10-31
RU2012154628A (ru)	2014-06-27
BR112012029171B1 (pt)	2021-05-25
CA2798575A1 (en)	2011-11-24
PL2571488T3 (pl)	2014-12-31
CN102892410B (zh)	2014-12-10
AU2011254583B2 (en)	2014-04-10
MA34176B1 (fr)	2013-04-03
ES2478491T3 (es)	2014-07-22
AU2011254583A1 (en)	2012-11-08
TN2012000487A1 (en)	2014-04-01
SI2571488T1 (sl)	2014-09-30
JP6018048B2 (ja)	2016-11-02
CR20120559A (es)	2013-02-15
RS53408B2 (sr)	2018-06-29
DK2571488T4 (da)	2017-08-28
MY160302A (en)	2017-02-28
PL2571488T5 (pl)	2018-07-31
US9114165B2 (en)	2015-08-25
CO6650419A2 (es)	2013-04-15
EP2571488A1 (en)	2013-03-27
UA103290C2 (ru)	2013-09-25
CA2798575C (en)	2018-08-28

Publication	Publication Date	Title
SMT201700008B (it)	2017-03-08	Composizione farmaceutica
SMT201600350B (it)	2016-11-10	Composizioni farmaceutiche
DK3246018T3 (da)	2022-01-17	Farmaceutisk sammensætning
DK2694038T3 (da)	2019-08-19	Farmaceutisk sammensætning
DK2654736T3 (da)	2020-09-14	Hidtil ukendt farmaceutisk sammensætning
DK2462116T3 (da)	2014-10-13	Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
DK2389918T3 (da)	2013-06-17	Anordning til indgivelse af væske i næse-øre-hals-området
BR112014003052A2 (pt)	2017-03-01	composições farmacêuticas
DK2482899T3 (da)	2014-01-06	Konstruktion til indretning til indgivelse af lægemiddel
DK2704703T3 (da)	2019-10-14	Transdermale sammensætninger af ibuprofen og fremgangsmåder til anvendelse deraf
BRPI1004940A2 (pt)	2018-06-19	composição farmacêutica
EE201300005A (et)	2013-08-15	Ravimkoostis
CO6930367A2 (es)	2014-04-28	Composiciones farmaceúticas
DK3603704T3 (da)	2023-07-24	Indgivelse af medikament
EP2642979A4 (en)	2014-09-17	PHARMACEUTICAL COMPOSITION
HUE040370T2 (hu)	2019-03-28	Gyógyszerkészítmények
BR112013000356A2 (pt)	2016-06-07	formulação farmacêutica injetável de malfalano
CO6801722A2 (es)	2013-11-29	Composiciones farmacéuticas
EP2769718A4 (en)	2015-07-01	MEDICAL COMPOSITION
DK3524260T3 (da)	2023-10-09	Farmaceutiske sammensætninger til behandling af manglende appetit
BR112012003149A2 (pt)	2016-03-01	composição farmacêutica
DK2571488T3 (da)	2014-07-14	Farmaceutisk komposition af ibuprofen til injektion
BR112013007469A2 (pt)	2016-07-19	composições farmacêuticas antidiabéticas sólidas
BR112012029461A2 (pt)	2017-03-01	composição farmacêutica contendo solifenacina
DK2655360T3 (da)	2016-08-15	Fremgangsmåde til fremstilling af n-sulfonylsubstituerede oxindoler